Sustainability news

February 2015 - Novo Nordisk publishes 2014 integrated Annual Report emphasising long-term thinking

Today Novo Nordisk published its 2014 Annual Report detailing the company’s performance. The report highlights the company’s progression towards long-term targets taking an integrated approach that accounts for financial, social and environmental performance. Read more 

January 2015 - Clinical trials: More than just safety and efficacy

The purpose of clinical research is to demonstrate the safety and efficacy of new medicine and the benefits they provide to patients. However, a new Blueprint for Change report now shows that added value for patients, healthcare professionals and communities is created beyond that primary purpose. Read more 

December 2014 - Top five sustainability stories of 2014

The readers have spoken! In 2014 Novo Nordisk celebrated 10 years as a company with a Triple Bottom Line approach to business. Throughout the year, Novo Nordisk shared stories and videos telling the actions and initiatives that demonstrate the company’s commitment to financial, environmental and social responsibility. Read more 

December 2014 - Novo Nordisk brings one-stop diabetes care to African cities

Today, Novo Nordisk opened its eleventh Diabetes Support Centre, improving access to affordable diabetes treatment in some of the largest cities in Ghana and Nigeria. The centres are part of the company’s Base of the Pyramid project to help improve diabetes care and lessen the financial burden of diabetes treatment for low-income groups. Read more 

December 2014 - Novo Nordisk places R&D under the microscope

A new medicine takes a 10 to 13 year journey from idea to patient. Along the way, scientists navigate uncertainty, ethical dilemmas and unmet patient needs. The latest issue of Novo Nordisk’s TBL Quarterly  talks about the power and responsibility of science. And there is much more than meets the eye. Read more 

November 2014 - Novo Nordisk shows path to lowering costs and improving diabetes care in Turkey

As a business concept, Creating Shared Value is increasingly being seen as a framework to guide and motivate corporate sustainability efforts. The company’s newest case study looks at how best to provide good diabetes care for the growing number of people with diabetes in Turkey. Read more

October 2014 - Novo Nordisk once again included in the CDP Nordic Climate Disclosure Leadership Index

With a score of 97 B, Novo Nordisk has been awarded with a position on the Nordic Climate Disclosure Leadership Index (CDLI), released on 15 October 2014 in the CDP Nordic 2014 report - Natural capital disclosure for business resilience. The score threshold of entering to the Nordic CDLI rose to a 95 in 2014. Read more 

September 2014 - Novo Nordisk puts focus on health in the Middle East and North Africa 

Today, many parts of the Middle East and North Africa struggle with conflict and civil unrest. What is perhaps less known is the threat diabetes poses, responsible for 367,700 premature deaths each year (1). The new issue of Novo Nordisk’s TBL Quarterly tells the stories about the actions that are taken to create better health in the region. Read more  

September 2014 - In Indonesia, Novo Nordisk is Diabetes CSR Company of the Year 

Novo Nordisk is honoured for its contributions to making Indonesians healthier, winning Frost & Sullivan’s 2014 Diabetes CSR Company of the Year Award. Read more  

September 2014 - Calling for a life-course approach in post-2015 development agenda 

Non-communicable diseases (NCDs) are not just a health issue, but a critical and cross cutting development issue that threatens social and economic progress in many parts of the world. The post-2015 development agenda is an opportunity to steer a healthier course for both current and future generations. Read more 

September 2014 - Novo Nordisk advocates for health on the post-2015 development agenda 

Eight million people below the age of 60 die each year in low- and middle- income countries from preventable causes, including unhealthy diets, alcohol consumption and physical inactivity leading to non-communicable diseases (NCDs).  Addressing the drivers of NCDs should play a central part of the next round of development goals. Read more  

September 2014 - Novo Nordisk remains in the top of 2014 Dow Jones Sustainability Indices

Novo Nordisk’s scores 84 in the 2014 Dow Jones Sustainability Indices and retains a leading position in the pharmaceutical industry. Read more  

June 2014 - Mandatory CSR in India means business as usual for Novo Nordisk

For two decades, Novo Nordisk has been working to support the Indian healthcare infrastructure to cope with the millions of people living with diabetes. Going beyond philanthropy, the company has taken a holistic approach to diabetes care, raising awareness of diabetes, building healthcare professionals’ capabilities and educating patients. Read more 

June 2014 - Measuring the value of partnerships to change diabetes in India

Today, Novo Nordisk published its sixth business case, Developing partnerships to change diabetes in India, demonstrating the shared value the company creates through its business activities. Read more

May 2014 - Green solutions can reverse rise in chronic diseases

Tackling the world’s no. one health threat, chronic diseases, can include green benefits. New publication on health promotion and disease prevention documents new sustainability potential for companies, schools and local cities. Read more 

May 2014 - Novo Nordisk wins two awards for its 2012 reporting

Novo Nordisk’s 2012 Annual Reports is honoured as the Best Integrated Report and having the most Credibility Through Assurance at the 2014 Corporate Register Reporting Awards. Read more 

April 2014 - Novo Nordisk joins the Trillion Tonne Communiqué

Calling for action to keep global carbon emissions under one trillion tonnes, Novo Nordisk joins the global business community in signing the Trillion Tonne Communiqué. Read more

February 2014 - The story of Novo Nordisk's Environmental Profit and Loss account

Together with the Danish Ministry of Environment, Novo Nordisk has released the pharmaceutical industry's first Environmental Profit and Loss (E P&L) account identifying the costs and areas for reduction related to water consumption, greenhouse gas (GHG) emissions and air pollution. Read more 

February 2014 - Leaders gather to address growing diabetes pandemic in Latin America

More than 37 million people are currently living with diabetes in Latin America. Together with partners, Novo Nordisk is taking steps to tackle the growing diabetes pandemic in the region with a Latin American High Level Meeting on Diabetes. Read more 

February 2014 - Novo Nordisk 2013 Annual Report marks 10 years of integrated reporting

Today Novo Nordisk published its 2013 Annual Report  detailing the company’s social, environmental and financial results for 2013. The report highlights the company’s progression towards long-term targets during a year of challenges and setbacks.  Novo Nordisk has taken an integrated approach to reporting since 2004, accounting for social, environmental and financial performance. Read more 

January 2014 - Beating the benchmark: Novo Nordisk drives the Global 100 index

This week, the Corporate Knights Global 100 Most Sustainable Companies index was released at the World Economic Forum in Davos. Although down two places from last year in the overall ranking, Novo Nordisk was recognised for its strong and consistent performance throughout the past decade. Read more 

January 2014 - Mexican employees turn company values into action with hurricane relief efforts

When two hurricanes hit Mexico in September 2013, Novo Nordisk employees stepped up to keep essential food, basic goods and insulin supply lines open. In recognition of their response, Novo Nordisk Mexico took home the company’s 2013 TakeAction award. Read more 

December 2013 - Five sustainability stories not to be missed!

2013 is coming to an end and many actions and initiatives have shaped the past year’s sustainability news stories. Here is a recap on the most popular sustainability reads from Novo Nordisk. Read more

December 2013 - Novo Nordisk rewards employees who improve the lives of research animals

For the 5th year in a row, Novo Nordisk honours employees who bring the company’s commitment to 'Reduce, Refine or Replace' (3R) the use of animals in research into action. Read more 

November 2013 - What does it mean to go the extra mile to improve access to health?

Novo Nordisk’s TBL Quarterly magazine tells the stories of the individuals that are making a difference for people living with diabetes. Read more 

October 2013 - Novo Nordisk and DONG Energy share experiences with energy savings

A partnership model has secured Novo Nordisk energy savings of close to DKK 50 million as well as significant CO2 emission reductions. A new publication shows how it is done. Read more 

October 2013 - Novo Nordisk recognised for climate change transparency with CDP leadership position

Novo Nordisk sends a strong signal to stakeholders on its efforts to reduce carbon emissions and the quality of disclosure. Read more 

October 2013 - Novo Nordisk South Africa leads industry as a ‘best place to work’

Novo Nordisk South Africa was ranked number 1 in the Deloitte Best Company to work for survey of 2013 in the Chemical and Pharmaceutical category. Read more 

September 2013 - Novo Nordisk supports new Guiding Principles on Access to Healthcare

Business for Social Responsibility (BSR), together with CEOs from 13 pharmaceutical companies, released a new set of Guiding Principles on Access to Healthcare (GPAH). The principles are an industry-led call for more cross-sector collaboration to expand access to quality healthcare. Read more 

September 2013 - Two sustainability rankings recognise Novo Nordisk for continued strong performance

Novo Nordisk received top placement in the Dow Jones Sustainability Index (DJSI) and the Carbon Disclosure Project (CDP), two of the most influential rankings of sustainability performance and disclosure by private companies. Read more 

August 2013 - Novo Nordisk finds responsible production in unusual places

Novo Nordisk publishes its second issue of the company’s digital sustainability magazine – The TBL Quarterly. The content in the new issue, Responsible Production, explores the successes and challenges of managing the company’s environmental impact at its global insulin production sites. Read more 

August 2013 - Novo Nordisk Japan switches to renewable energy at Koriyama factory

Aiming for zero CO2 emissions from electricity energy consumption, Novo Nordisk Pharma Ltd. In Japan will convert all electricity supplied to the company’s Koriyama factory to renewable energy. Read more 

June 2013 - Novo Nordisk partners to advance alternatives to animal research

Together with industry partners and animal welfare groups, Novo Nordisk supports the creation of a new centre to develop alternatives to animal research and improve animal welfare established by the Danish Ministry of Food and Agriculture. Read more

May 2013 - Novo Nordisk’s approach to sustainability goes digital

Today, Novo Nordisk publishes the first issue of the company’s new digital sustainability magazine – The TBL Quarterly. The Q1 issue shows how Novo Nordisk is changing diabetes in Vietnam, Malaysia and Indonesia, from prevention to educating healthcare professionals on how to diagnose and treat diabetes. Read more

May 2013 - Novo Nordisk honoured for Best Integrated Report

Novo Nordisk's 2011 Annual Report was named the Best Integrated Report at the Corporate Register Reporting Awards in London on 29 April. The award was given to the company that best combines non-financial aspects into their annual report, integrating the financial and non-financial aspects throughout. This is the fifth time Novo Nordisk has won the award. Read more

April 2013 - Novo Nordisk earns top green ranking in China

Novo Nordisk was named as one of the top 100 sustainable companies at the Annual Summit of Green Companies held in Kunming, China. The annual event assesses sustainable competitiveness of enterprises doing business in China. On the Annual Summit’s ‘China Top 100 Green Companies 2013’ list, Novo Nordisk ranked number five in the multi-national company category. It is the first time the company has been selected. Read more

April 2013 – Commenting period opens on new integrated reporting framework

Today the International Integrated Reporting Council (IIRC) published its consultation draft of the International Integrated Reporting Framework. The Framework aims to set standards for organisations reporting their strategy, governance, performance and prospects with a view towards the creation of value over the short, medium and long term. Stakeholders are invited to respond to the consultation draft between 16 April and 15 July. Read more 

April 2013 – A blueprint for changing diabetes in Indonesia

4 April 2013: Among the 242 million people living in Indonesia, 7.6 million have diabetes but less than one per cent is achieving recommended treatment targets. In its fifth Blueprint for Change business case published today, Novo Nordisk examines four barriers that prevent quality and accessibility of diabetes care and identifies the opportunities to address them. Read more 

March 2013 – Novo Nordisk gets a jump start on International Women’s Day

8 March: On 1 March, Novo Nordisk celebrated International Women’s Day early with the launch of a new career network – WINN2. The new network stems from the original WINN network (Women in Novo Nordisk) which aims to advance and develop women in management positions to drive business performance. But unlike the original network, WINN2 was created for women at earlier stages of their careers. Read more 

February 2013 – Novo Nordisk annual report integrates sustainability and business strategy

4 February: Today Novo Nordisk published its ninth integrated annual report detailing the company’s social, environmental and financial results for 2012. The 2012 report describes how Novo Nordisk’s Triple Bottom Line business principle continues to support the company’s long-term value creation. Read more 

February 2013 – Novo Nordisk joins other biotech leaders to drive sustainable production

1 February 2013, Kalundborg, Denmark: Today, the BIOPRO development center was launched to begin developing solutions to biotechnological production challenges. The two-year project is the start of a collaboration between Danish universities and world-leading companies in the biotechnology production. Read more 

January 2013 – Novo Nordisk leads industry in sustainability

At the World Economic Forum in Davos, Switzerland, Novo Nordisk received the top position in the Pharmaceuticals and Biotechnology industry group of the Global 100 Most Sustainable Corporations in the World index. Read more 

January 2013 - Syrian employees ensure supply of medicine during conflict

16 January 2013 – Syrian employees ensure supply of medicine during conflict. Read more 

November 2012 - Novo Nordisk recognised for improving access to medicine

28 November 2012 – Today, Novo Nordisk moves up two places to number 6 in the 2012 Access to Medicine Index. Read more 

November 2012 - Novo Nordisk partners with Ministry of Health to prevent diabetes

14 November 2012 – Today, Novo Nordisk entered into a public private partnership with the Malaysian Ministry of Health to prevent diabetes through a health promotion programme targeting young couples. Read more 

November 2012 - Reaching millions with a message for change

1 November 2012 – Today, Novo Nordisk launched its 1,000,000 Blue Circles for Change campaign to raise the profile of the World Diabetes Day blue circle symbol. Read more 

October 2012 - Novo Nordisk, Schwarzenegger and Nobel Sustainability Trust celebrate sustainable solution

11 October 2012 – Today, Novo Nordisk joins Sustainia partners when former Governor Arnold Schwarzenegger will announce the winner of the first Sustainia Award in front of an audience of more than 1,000 people at the Royal Theater in Copenhagen. Read more 

September 2012 - Global sustainability goals must integrate health

25 September 2012 – Today, in New York, Novo Nordisk’s Executive Vice President Lise Kingo will kick-start the discussion on the role of business in shaping a new set of global sustainability goals to replace the Millennium Development Goals (MDGs). Read more 

September 2012 - Dow Jones Sustainability Index: Novo Nordisk receives top environmental and social score

13 September 2012 – Today, the results of Sustainability Asset Management’s (SAM) rating for the Dow Jones Sustainability Index were released with Novo Nordisk achieving a score of 86 out of 100, the second highest in the pharmaceutical sector. Read more 

September 2012 - Novo Nordisk maintains leading position in climate disclosure ranking

Novo Nordisk remained in the top 10 of healthcare companies in the Carbon Disclosure Project (CDP) Global 500 2012 report. Read more 

September 2012 - Empowering children with type 1 diabetes in Africa

On September 7 2012 the Changing Diabetes® in Children Dialogue Posters, an education resource to help guide the treatment dialogue between healthcare professionals and children with type 1 diabetes and their families, is being launched. Read more 

August 2012 - Novo Nordisk gives graduates new perspective on business

Working for a pharmaceutical company is more than just selling medicine. A message Novo Nordisk embeds throughout its 2-year graduate programme. Read more 

June 2012 - Rio+20 ends with commitment to health

What’s the point in saving the planet, if you don’t save its people? Novo Nordisk came to the United Nations Conference on Sustainable Development in Rio de Janeiro with the goal of placing health on the sustainability agenda, and a hope that non-communicable diseases (NCD's) would be acknowledged as a major challenge for sustainable development. Read more 

June 2012 - Novo Nordisk's sustainability journey: 1992 - 2012

In a new publication launched to mark the 20 year anniversary of the Rio Declaration, Novo Nordisk looks back on two decades of challenges and successes as a sustainable business. Read more 

June 2012 - Novo Nordisk reporting acknowledged with the C20 accounting award

On 12 June Novo Nordisk’s 2011 Annual Report was honoured with the 2012 C20 accounting award (C20 Regnskabsprisen). Read more 

June 2012 - Turning diabetes policy into action – Copenhagen Roadmap

With more than 35 million Europeans living with diabetes today and 43 million expected to live with the condition in 2030 , the Copenhagen Roadmap was launched to support initiatives to improve prevention, detection and management of diabetes. Read more 

June 2012 - Novo Nordisk's Triple Bottom Line yields shared value

In the company’s fourth Blueprint for Change case study, Novo Nordisk provides evidence that its Triple Bottom Line business approach has resulted in higher quality and access to diabetes treatment in Bangladesh. Read more

May 2012 - How to say ’Triple Bottom Line’ in Chinese

In 2011, Novo Nordisk China seized an opportunity that led to a 17% reduction in electricity and a 40% reduction in paper. After moving headquarters to Beijing’s World Financial Center building, employees at Novo Nordisk China created and implemented a strategy to improve the environmental performance of their new 10,000 square metre office. Read more 

April 2012 - Novo Nordisk takes home Best Sustainability Performance award

On Wednesday, 25 April Novo Nordisk received the Justmeans Best Sustainability Performance award at the 2012 Social Innovation Awards. The award recognised Novo Nordisk’s energy saving partnership with DONG Energy and the World Wide Fund for Nature that resulted in Denmark’s Horns Rev 2 wind farm as well as helping Novo Nordisk achieve its 2014 CO2 emission reduction target. Read more 

April 2012 - Novo Nordisk honoured for Best Integrated Report

Novo Nordisk's 2010 Annual Report was honoured as the Best Integrated Report at the 19 April 2012 CR Reporting Awards in London. This is the fourth time Novo Nordisk has won the award for its efforts to reflect the company’s objective to ‘strive to conduct our activities in a financially, environmentally and socially responsible way’. Read more 

April 2012 - Ambition: change diabetes in Cambodia

On 1 April 2012, Novo Nordisk launched the third ‘Diabetes Care’ mobile clinics in Cambodia. The mobile clinics are part of the company’s strategy in Cambodia to improve access to healthcare and make diabetes treatment affordable in rural communities. Essential medication, including insulin for $5 a month from Novo Nordisk, is made available for managing diabetes. Read more 

February 2012 - Novo Nordisk reports solid financial, social and environmental performance in 2011

BAGSVÆRD, Denmark, 7 February 2012 – Novo Nordisk’s eighth annual integrated report, now online, reports on the company’s very positive financial, social and environmental performance for 2011. Read more

January 2012 - Novo Nordisk demonstrates shared value through social responsibility initiatives in the United States

In its third Blueprint for Change business case, Novo Nordisk analyses how aligning business strategy with the needs of patients, stakeholders and society has contributed to business success and has helped improve quality of care, early diagnosis and diabetes prevention in the United States. Read more

January 2012 - Novo Nordisk tops global list of 100 most sustainable companies

Today at the World Economic Forum in Davos, Switzerland, Novo Nordisk was ranked number one in the Global 100 Most Sustainable Corporations in the World index. The index is published annually since 2005 by Corporate Knights – a Canadian and North American business magazine. Read more 

November 2011 - Supplement on maternal health and noncommunicable diseases

On 18 November 2011, a supplement made possible through an unrestricted educational grant by Novo Nordisk was published by the International Journal of Gynecology and Obstetrics. The supplement, “From biology to policy: The link between maternal health and current and future burden of chronic noncommunicable disease”, brings increased awareness on the foundation for lifelong risk and susceptibility of non-communicable diseases, focusing on root causes beginning in the womb and in early life — now referred to by the term Developmental Origins of Health and Disease. Read more 

October 2011 - Novo Nordisk supports gestational diabetes treatment in Colombia

In October 2011, the Health Secretary of Barranqilla with support from Novo Nordisk launched the “Vida Nueva” (New Life) Project for Gestational Diabetes in Barranquilla, Colombia. Vida Nueva, a key activity in Novo Nordisk’s Changing Diabetes® in Pregnancy programme, seeks to diagnose and treat women with gestational diabetes and prevent the women and their babies from developing type 2 diabetes in the future. Read more 

September 2011 - Novo Nordisk supports global dialogue on integrated reporting

Novo Nordisk has published integrated annual reports since our 2004 reporting cycle and we have long advocated for widespread adoption of integrated reporting. We therefore welcome the efforts of the International Integrated Reporting Committee to develop an international integrated reporting framework which ultimately could lead to an international standard for reporters and report users. We believe that agreement on how to move from reporting silos to integrated reporting is very important and we have been pleased to be part of discussions related to this process. Read more

September 2011 - Global 500 improves carbon management and disclosure

For the first time in the ten year history of the Carbon Disclosure Project survey, the majority of respondents in the Global 500 report have climate change actions embedded as part of their business strategy. Novo Nordisk has participated in the Carbon Disclosure Project since 2003. Novo Nordisk’s disclosure score has improved over the years from 56 in 2008 to 73 in 2009 and 89 in 2010 and 2011. Read more

September 2011 - Novo Nordisk in the lead of the Dow Jones Sustainability Index

With 86 out of 100 percent, Novo Nordisk improves its score in the Dow Jones Sustainability Index announced by Sustainable Asset Management (SAM) on 8 September, 2011. Novo Nordisk’s 2010 score was 84. For 2011, the average score for companies in the Healthcare sector is 53. Read more

September 2011 - Screening in Portugal to raise awareness

On Friday 2 September, the Novo Nordisk Changing Diabetes® World Tour established a mobile clinic in Lisbon’s Rossio Square offering free diabetes screening for adults between the ages of 30 and 75. The clinic has been set-up in connection with the 2011 Annual Meeting of the European Association for the Study of Diabetes (EASD) and will run until Thursday 15 September. Read more

June 2011 - Novo Nordisk China wins CSR award

On 15 June 2011 at the Sixth Golden Bee International CSR Forum in Beijing, Novo Nordisk received the Harmonious Contributors Award for its sustainability commitment and achievements. The Award was announced as part of the 2010 Golden Bee CSR Honor Roll, recognising companies in areas of customer focus, employee care and responsible purchasing. Read more

June 2011 - Novo Nordisk discusses integrated reporting

In April 2011, Novo Nordisk took part in Global Reporting Institute's Reporting Practice series on sustainability reporting. In the series, Novo Nordisk's Director for Corporate Accountability, Susan Blesener, provided answers to questions on the company's integrated reporting. Read more

May 2011 - Novo Nordisk Pakistan wins 2010 TakeAction award

In recognition of their rapid response to last year's devastating floods in Pakistan, employees from Novo Nordisk Pakistan were voted the 2010 TakeAction award winners. The award, given to the most impressive employee volunteer activity of the year, was announced at Novo Nordisk's International Management meeting held from May 11 - 13. Read more

April 2011 - Dealing with dilemmas when implementing a global climate strategy

On April 6, Novo Nordisk Global TBL Management engaged with students from Copenhagen Business School to involve them in answering five dilemmas we face in our efforts to improve energy efficiency and reduce CO2 emissions. Read more

March 2011 - Novo Nordisk's reporting acknowledged with two awards in London

On March 24 and 25, Novo Nordisk's 2009 Annual Report was the winner of two awards given out by CorporateRegister, a worldwide resource for corporate responsibility reporting, and JustMeans, a corporate social responsibility news service. Read more

March 2011 - Novo Nordisk demonstrates shared value in China

In our second Blueprint for Change Programme business case, Novo Nordisk reports that its Triple Bottom Line business principle, balancing economic, social and environmental decisions, has created value for both the Chinese society and Novo Nordisk. Read more

March 2011 - Changing diabetes with a local touch

In 2010, Novo Nordisk continued to develop and provide treatments that improve the lives of people affected by diabetes. As the global diabetes pandemic worsens, with current estimates predicting that 438 million people will be living with diabetes by 2030, Novo Nordisk realises that reversing this trend takes more than just a global approach. Changing diabetes requires local initiatives and actions that take into consideration local needs, societies and cultures. Read more

March 2011 - Novo Nordisk awarded Gold Class distinction by Sustainability Asset Management

In its Sustainability Yearbook 2011, Sustainability Asset Management (SAM) has awarded Novo Nordisk the Gold Class distinction, recognising the company’s strong performance on economic, environmental, and social issues that focus on long-term value creation. Novo Nordisk was one of four companies in the pharmaceutical sector to have received the Gold Class distinction. Read more

January 2011 - Novo Nordisk climbs global list of 100 most sustainable companies

Novo Nordisk moved up 33 positions to rank 16th in the 2011 Global 100 Most Sustainable Corporations. Corporate Knights, the magazine for clean capitalism, announced the results from its seventh annual Global 100 list on January 29 at the Davos World Economic Forum. Read more

January 2011 - Novo Nordisk commits to adopt Ambitious Sustainability Roadmap in Davos

Underscoring the role of business in addressing global threats - from climate change to widespread poverty or humanitarian emergencies - a group of chief executives joined UN Secretary-General Ban Ki-moon in Davos/Switzerland today for the launch of Global Compact LEAD - a new platform created by the UN Global Compact to take environmental, social and governance performance to the next level and set a new benchmark for corporate sustainability. Read more

January 2011 - Novo Nordisk tweets on sustainability

Twitter users can now follow Novo Nordisk's corporate sustainability activities, performance and dilemmas. The new Twitter account will serve to expand Novo Nordisk's reporting of non-financial performance and how it manages its business. Read more

December 2010 - Novo Nordisk praises historic declaration to fight diabetes

On December 13, 2010, twenty-two countries from the Middle East and Northern Africa (MENA) and five international organisations agreed on the "Dubai Declaration on Diabetes and Chronic Non-Communicable Diseases in the Middle East and Northern Africa Region." The agreement was the culmination of the Novo Nordisk sponsored MENA Diabetes Leadership Forum held on December 12-13 in Dubai. Read more

December 2010 - Novo Nordisk welcomes new guidelines on human rights

On the occasion of the 62nd anniversary, Novo Nordisk welcomes the Draft Guiding Principles presented by Professor John Ruggie, Special Representative to the UN Secretary General, which elaborate and clarify for companies, states, and other stakeholders how they can put into practice their respective roles in the UN ‘Protect, Respect and Remedy’ Framework; the duty of states to protect human rights, the responsibility of business to respect these rights and the obligation for both to ensure appropriate mechanisms for remedy in cases of infringement. Read more

December 2010 - Diabetes awareness survey reveals alarming figures across the Middle East and Northern Africa regions

In the lead up to World Diabetes Day 2010 on 14 November Novo Nordisk and Ipsos Emirates Health conducted a survey in ten countries of the Middle East and Northern Africa (MENA) region. The survey, which was carried out in October this year, assesses the level of awareness among the general population when it comes to causes, risks and complications of diabetes. It also looks into respondents’ risk of developing diabetes. With over 3,000 interviews, the respondents were representative of the demographic and socio-economic profile in each country. Read more

December 2010 - Diabetes screening initiative launched in Dubai

The Changing Diabetes® World Tour initiative is providing free diabetes screening and raising awareness about diabetes in the United Arab Emirates. The objective of the Changing Diabetes® World Tour is to help identify people who have diabetes or are at high risk of developing diabetes without knowing it. Read more

November 2010 - Global companies call for climate action in Cancun

On November 15, 2010 Novo Nordisk joined the nearly 1000 global companies in signing The Cancun Communiqué urging governments to make rapid progress on a number of key issues during the sixteenth United Nations Climate Change Conference of the Parties (COP16) in Cancun, Mexico. Read more

November 2010 - Novo Nordisk hands out award for for innovation in paediatric diabetes care

Dr Manuel Vera González is the 2010 winner of the International Society for Paediatric and Adolescent Diabetes (ISPAD) Award for Innovation in Paediatric Diabetes Care. The prize, supported by Novo Nordisk within its DAWN™ Youth Initiative, was given to the professional, group or individual who has made a significant innovation in paediatric diabetes care. Read more

October 2010 - Official partner of Copenhagen Competition 2010 on Access to Medicines

From 13 - 15 October law students from 15 universities around the world met in Copenhagen to tackle the dilemma between access to medicines and patent regulations in low and middle income countries. A daunting task but one that health organisations, governments and Novo Nordisk see as critical to providing safe, effective and affordable medicines for all. Read more

October 2010 - African health leaders gather to address significant rise in diabetes

With the incidence of diabetes rising at an alarming rate worldwide, UN member states have resolved to host a summit in 2011 on this growing healthcare threat. In preparation for this, South Africa hosted the Diabetes Leadership Forum Africa 2010 (DLFA) in Johannesburg on 30 September and 1 October. Read more

September 2010 - Novo Nordisk climbs to the top ranks of climate management

In its latest ranking released in New York on 20 September, the Carbon Disclosure Project includes Novo Nordisk on the lists of the world’s leading companies within carbon disclosure and carbon performance. Read more

September 2010 - Novo Nordisk in the top of DOW Jones Sustainability Indexes

With 84 out of 100 points, Novo Nordisk keeps its position in the top of the DOW Jones Sustainability Indexes announced by SAM on 9 September, 2010. The top score in the healthcare sector was 85, average score 53. Read more

August 2010 - Improving access to diabetes care for children in Cameroon

In June, Novo Nordisk and the Minister of Public Health in Cameroon announced a partnership to address the needs for children with diabetes in Cameroon. The project is part of the Novo Nordisk Changing Diabetes® in Children programme which was launched in 2008. Read more

August 2010 - Novo Nordisk reaches out to Pakistani flood victims

On 10 August Novo Nordisk decided to donate 1 million Danish kroner to help flood victims in Pakistan. Read more

August 2010 - Global framework for integrated reporting on its way

On 2 August the International Integrated Reporting Committee was formed with the objective of creating a globally accepted framework for accounting for sustainability in order to develop a more comprehensive information about an organisation's total performance. Read more

June 2010 - Novo Nordisk commits to women's empowerment

At the UN Global Compact Leaders Summit, taking place in New York last week, Novo Nordisk committed to support the Women’s Empowerment Principles. Read more

June 2010 - Innovative approach recognised in Access to Medicines Index

In the 2nd Access to Medicines Index (ATMI), released in Amsterdam Monday 21 June, Novo Nordisk ranks 8th among 20 research-based pharmaceutical companies. Read more

June 2010 - Employees renovate a school in Morocco

About 350 employees from Novo Nordisk went to Marrakech to take part in the Global Brand Summit. One issue at the agenda stood out from the rest: Restoration of a primary school in a nearby village. Read more

May 2010 - Storebrand rates Novo Nordisk ‘Best in Class’

In its latest rating of pharma companies, the Norwegian financial services company, Storebrand, has awarded Novo Nordisk a ‘Best in Class’ status for leading financial, environmental and social performance. Read more

May 2010 - Ethics e-learning tools launched by Novo Nordisk and the University of Copenhagen

Thursday 21 May Novo Nordisk and the University of Copenhagen launched two new e-learning tools at the ISO-26000 meeting in Copenhagen. More than 450 delegates from around the globe were invited to test their ethics decision-making skills and to get to know their personal ethics profiles. Read more

May 2010 - Global standard on social responsibility enters final round

Monday 17 May the 8th and final meeting on the upcoming ISO standard on social responsibility opens in Copenhagen. Read more

April 2010 - Corporate Register awards Novo Nordisk for best integrated report

Novo Nordisk's 2008 Annual Report was named the Best Integrated Report at the CR Reporting Awards 2010. Read more

April 2010 - Novo Nordisk launches HERO

Novo Nordisk announced today the start of a global survey into the psychological and social effects of haemophilia named HERO. Read more

April 2010 - Novo Nordisk on World Haemophilia Day

The 17 April 2010, World Haemophilia Day (WHD), was celebrated by Novo Nordisk along with the global haemophilia community. The primary aim of this 21st celebration of WHD is to promote knowledge and understanding of haemophilia. Read more

April 2010 - UK Business award to Novo Nordisk

Through demonstrating a company wide commitment to Corporate and Social Responsibility (CSR) in the UK between 2006 and 2009, backed by evidence of collaboration and partnership between business and community organisations, Novo Nordisk UK was announced winner of the 2010 CSR award. Read more

March 2010 - 30% cut in CO2 emissions

During a period of double-digit growth rates Novo Nordisk has decoupled its business growth from its CO2 emissions and now we are busy setting new goals - what is next going forward? Read more

March 2010 - Sustainable contributions from our profits

Our community investments are focused on making a difference towards people with diabetes. They are long term business investments that make employees proud and build good relations with stakeholders. Read more

February 2010 - Health programme reaches 80% of our people

NovoHealth seeks to develop a workplace culture that promotes supports and inspires healthy living for all employees through four global standards, offered to all employees and adopted locally by the company's affiliates. Read more

February 2010 - Annual report 2009 published

Despite continuing challenges in the global economic environment, 2009 was a successful year for Novo Nordisk with solid sales in all business areas, and the three bottom lines, financial, social and environmental. Read more

January 2010 - Employee volunteering on the rise

Novo Nordisk’s employees care about their community and conceived and carried out more TakeAction! activities in 2009 than ever before since the launch of the global volunteer programme. Read more

October 2009 - Novo Nordisk wins award for best annual report in Denmark

On 1 October Novo Nordisk received several awards, including the award for best annual report in Denmark, at an award ceremony at the historical stock exchange building in Copenhagen. Read more

September 2009 - Novo Nordisk improves carbon disclosure

Novo Nordisk’s disclosure score was up by 17 points from 56 in 2008 to 73 in 2009. Read more

September 2009 - Novo Nordisk among top five in DOW Jones Sustainability Indexes

With 85 out of 100, Novo Nordisk improves its score in this year’s DOW Jones Sustainability Indexes, announced by SAM on 3 September, 2009. Read more

July 2009 - Novo Nordisk among the world's top 20 sustainable stocks

As the only health care company Novo Nordisk has been listed among the world’s most sustainable stocks. Read more

June 2009 - Globe Award for sustainability reporting awarded to Novo Nordisk

The Globe Sustainability Reporting Award 2009 was awarded to Novo Nordisk on 3 June by H.R.H Crown Princess Victoria of Sweden. Read more

May 2009 - ’The Copenhagen Call’: Six Steps for Ambitious Climate Treaty

Tuesday 26 May, global business leaders assembled in Copenhagen at the World Business Summit on Climate Change issued "The Copenhagen Call. Read more

May 2009 - Diabetes film wins two International Gold Film awards

In May, a diabetes film won two International Gold Film awards at the WorldMediaFestival in Hamburg. Read more

February 2009 - Novo Nordisk among the 100 most sustainable companies world wide

At this year's World Economic Forum held in Davos, Novo Nordisk was once again rated among the 100 most sustainable companies in the world. Read more